The Future Perspectives of Redefining the Resection Margin Status in Different Cancers of Pancreas
DOI:
https://doi.org/10.3889/oamjms.2022.9867Keywords:
Pancreatic cancer, R1 resection, Circumferential resection marginsAbstract
Background: The interest towards the assessment of circumferential resection margins(CRM) in pancreatic cancers has been evolving over last years. Whilst several studies investigated the influence of R1-resections on survival, not many studies evaluated the prognostic value of each resection margin. In this study, we examined the different resection margins to better understand their prognostic implications on overall survival.
Methods: This prospective study included a cohort of patients who had pancreaticoduodenectomy for cancer purposes at our institution from 2008 till 2013. Median follow-up was 6 years. Involved margins in R1-resections were further classified into anatomical margins (anterior, posterior and circumferential margins) and surgical margins (vascular/medial margins and transection margins). Overall survival was assessed for each specific resection margin.
Results: 134 patients were included with median age 66 years. R1-resection was done in 54% of patients(n=72/134). Median survival of R0-resection group was 6.3 years, compared to 1.9 years for R1-resection group(p-value 0.001). Vascular (surgical) margins had the lowest survival rate (1.7years) compared to anatomical margins (anterior, posterior and circumferential margins) with 3.6, 2.2 and 2.1 years respectively (p-value 0.02). On multivariate analysis; lymph node involvement and vascular resection were the only factors to correlate significantly with poor survival.
Conclusion: Whilst the new pathological protocols advised to perform rigorous margin assessment of CRM, the prognostic value of each resection margin is still unclear. This study showed variation of survival across different resection margins with inferiority towards vascular (surgical) margins. This supported the need of redefining R1-margins in the future pathological classifications according to their different prognostic impacts.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
GBD 2017 Pancreatic Cancer. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934-47. https://doi.org/10.1016/S2468-1253(19)30347-4 PMid:31648972 DOI: https://doi.org/10.1016/S2468-1253(19)30347-4
Hartwig W, Werner J, Jager D, Debus J, Büchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14(11):e476-e485. https://doi.org/10.1016/S1470-2045(13)70172-4 PMid:24079875 DOI: https://doi.org/10.1016/S1470-2045(13)70172-4
Gebauer F, Tachezy M, Vashist YK, Marx AH, Yekebas E, Izbicki JR, et al. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): Clinically relevant or just academic. World J Surg. 2015;39(2):493-9. https://doi.org/10.1007/s00268-014-2808-4 PMid:25270344 DOI: https://doi.org/10.1007/s00268-014-2808-4
Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, et al. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford). 2014;16(1):20-33. https://doi.org/10.1111/hpb.12061 PMid:23464850 DOI: https://doi.org/10.1111/hpb.12061
Jamieson NB, Chan, NIJ, Foulis AK, Dickson EJ, McKay CJ, Carter CR. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17(3):511-21. https://doi.org/10.1007/s11605-012-2131-z PMid:23297028 DOI: https://doi.org/10.1007/s11605-012-2131-z
Amin MB, Edge S, Greene F. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2016.
The Royal College of Pathologists. Standards and minimum datasets for reporting cancers. In: Dataset for the Histopathological Reporting of Carcinomas of the Pancreas, Ampulla of Vater and Common Bile Duct. London: The Royal College of Pathologists; 2010.
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93(10):1232-7. https://doi.org/10.1002/bjs.5397 PMid:16804874 DOI: https://doi.org/10.1002/bjs.5397
Demir IE, Jäger C, Schlitter AM, Konukiewitz B, Stecher L, Schorn S, et al. R0 Versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg. 2018;268(6):1058-68. https://doi.org/10.1097/SLA.0000000000002345 PMid:28692477 DOI: https://doi.org/10.1097/SLA.0000000000002345
Ghaneh P, Kleeff J, Halloran CM, Raraty M, Jackson R, Melling J, et al. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(3):520-9. https://doi.org/10.1097/SLA.0000000000002557 PMid:29068800 DOI: https://doi.org/10.1097/SLA.0000000000002557
Strobel O, Hank T, Hinz U, Bergmann F, Schneider L, Springfeld C, et al. Pancreatic cancer surgery: The new R-status counts. Ann Surg. 2017;265(3):565-73. https://doi.org/10.1097/SLA.0000000000001731 PMid:27918310 DOI: https://doi.org/10.1097/SLA.0000000000001731
Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP, et al. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology. 2009;55(3):277-83. https://doi.org/10.1111/j.1365-2559.2009.03376.x PMid:19723142 DOI: https://doi.org/10.1111/j.1365-2559.2009.03376.x
Klein F, Jacob D, Bahra M, Pelzer U, Puhl G, Krannich A, et al. Prognostic factors for long-term survival in patients with ampullary carcinoma: The results of a 15-year observation period after pancreaticoduodenectomy. HPB Surgery. 2014;2014:970234. https://doi.org/10.1155/2014/970234 PMid:24723741 DOI: https://doi.org/10.1155/2014/970234
Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, et al. Positive mobilization margins alone do not influence survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2010;251(6):1003-10. https://doi.org/10.1097/SLA.0b013e3181d77369 PMid:20485150 DOI: https://doi.org/10.1097/SLA.0b013e3181d77369
Chandrasegaram MD, Goldstein D, Simes J, Gebski V, Kench JG, Gill AJ, et al. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg. 2015;102(12):1459-72. https://doi.org/10.1002/bjs.9892 PMid:26350029 DOI: https://doi.org/10.1002/bjs.9892
Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs. observation on survival in patients with resected periampullary adenocarcinoma: The ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147-56. https://doi.org/10.1001/jama.2012.7352 PMid:22782416 DOI: https://doi.org/10.1001/jama.2012.14674
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology, Pancreatic Adenocarcinoma. Version 2; 2012. Available from: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf [Last accessed on 2021 Aug 25].
Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: A consensus statement by the international study group of pancreatic surgery (ISGPS). Surgery. 2014;155(6):977-88. https://doi.org/10.1016/j.surg.2014.02.001 PMid:24856119 DOI: https://doi.org/10.1016/j.surg.2014.02.001
Häberle L, Esposito I. Circumferential resection margin (CRM) in pancreatic cancer. Surg Pract Sci 2020;1:100006. DOI: https://doi.org/10.1016/j.sipas.2020.100006
Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, et al. Pancreatoduodenectomy for tumours of Vater’s ampulla: Report on 94 consecutive patients. World J Surg. 2005;29:513-8. https://doi.org/10.1007/s00268-004-7498-x PMid:15776300 DOI: https://doi.org/10.1007/s00268-004-7498-x
Zhou H, Schaefer N, Wolff M, Fischer HP. Carcinoma of the ampulla of vater: Comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol. 2004;28(7):875-82. https://doi.org/10.1097/00000478-200407000-00005 PMid:15223956 DOI: https://doi.org/10.1097/00000478-200407000-00005
Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H, et al. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg. 2005;22(5):353-63. https://doi.org/10.1159/000089771 PMid:16293966 DOI: https://doi.org/10.1159/000089771
Jarufe NP, Coldham C, Mayer AD, et al. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg. 2004;21(3):202-9. https://doi.org/10.1159/000079346 PMid:15218236 DOI: https://doi.org/10.1159/000079346
Van Eijck CH, Versteijne E, Suker M, Groothuis K, Besselink MG, Busch OR, et al. Preoperative chemoradiotherapy to improve overall survival in pancreatic cancer: Long-term results of the multicenter randomized phase III PREOPANC trial. J Clin Oncol. 2021;39(Suppl 15):4016. https://doi.org/10.1200/JCO.2021.39.15_suppl.4016 DOI: https://doi.org/10.1200/JCO.2021.39.15_suppl.4016
Downloads
Published
How to Cite
License
Copyright (c) 2022 Ahmed Elshaer, Tamer El-Sayed, Dowmitra Dasgupta (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
